Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 22, 2023

BUY
$36.12 - $47.5 $267,288 - $351,500
7,400 New
7,400 $296,000
Q4 2021

Feb 03, 2022

SELL
$47.97 - $62.21 $326,196 - $423,028
-6,800 Closed
0 $0
Q3 2021

Oct 21, 2021

SELL
$54.64 - $61.3 $38,248 - $42,910
-700 Reduced 9.33%
6,800 $381,000
Q1 2021

Apr 30, 2021

BUY
$59.31 - $78.82 $11,862 - $15,763
200 Added 2.74%
7,500 $526,000
Q4 2020

Feb 16, 2021

BUY
$50.47 - $66.26 $90,846 - $119,268
1,800 Added 32.73%
7,300 $437,000
Q3 2020

Nov 12, 2020

BUY
$51.97 - $63.0 $285,835 - $346,500
5,500 New
5,500 $331,000
Q3 2019

Oct 22, 2019

SELL
$35.66 - $44.99 $231,789 - $292,435
-6,500 Closed
0 $0
Q1 2019

Apr 25, 2019

BUY
$36.47 - $42.17 $237,055 - $274,105
6,500 New
6,500 $247,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $761M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.